State of Wyoming’s Theravance Biopharma TBPH Stock Holding History

State of Wyoming’s Portfolio TBPH Stock Details TBPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-22,007	Closed	-$357K	–	2232
2026 Q1	$357K	Sell	22,007 -2,880	-12%	-$51K	0.04%	563
2025 Q4	$466K	Sell	24,887 -5,865	-19%	-$97.3K	0.05%	404
2025 Q3	$449K	Buy	30,752 +11,824	+62%	+$149K	0.05%	375
2025 Q2	$209K	Buy	18,928 +1,019	+6%	+$9.91K	0.03%	888
2025 Q1	$160K	Buy	17,909 +4,758	+36%	+$44.3K	0.02%	937
2024 Q4	$124K	Buy	13,151 +841	+7%	+$7.65K	0.02%	1078
2024 Q3	$99.2K	Buy	12,310 +7,359	+149%	+$63.7K	0.01%	1143
2024 Q2	$42K	Buy	+4,951	New	+$44.7K	0.01%	1384
2022 Q3	–	Sell	-4,275	Closed	-$39K	–	1918
2022 Q2	$39K	Buy	+4,275	New	+$39.4K	0.02%	1100

Other funds holding TBPH

CAMG

CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

SSA

Sierra Summit Advisors Incline Village, Nevada $895M AUM 106% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

MCC

Money Concepts Capital Palm Beach Gardens, Florida $2.16B AUM 28.67% 1-Year Est. Return

STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Mitsubishi UFJ Trust & Banking Tokyo, Japan $45.7B AUM 34.08% 1-Year Est. Return

State of Wyoming's TBPH Position: Q2 2026 in Review

State of Wyoming sold out of Theravance Biopharma (TBPH) in Q2 2026, closing a stake of 22,007 shares — an estimated $357K sold.

State of Wyoming first reported a position in TBPH in Q2 2022 and held it in 9 quarters. The position peaked at $466K in Q4 2025. 46 funds tracked by Wall St. Rank hold TBPH as of Q2 2026.

State of Wyoming reported no remaining Theravance Biopharma position as of Q2 2026 after selling out during the quarter.
State of Wyoming sold 22,007 Theravance Biopharma shares in Q2 2026, an estimated $357K.
State of Wyoming first reported a position in Theravance Biopharma in Q2 2022 and held it in 9 quarters.
State of Wyoming's Theravance Biopharma position peaked at $466K in Q4 2025.
46 funds tracked by Wall St. Rank held Theravance Biopharma as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.